New alliance formed to immunise parents against vaccine fears News item 13 February 2013 Pages: 8 - 8
The healthcare systems of three European countries would be worth reviewing in regard to the upcoming debate over US healthcare reform, News item 13 February 2013 Pages: 9 - 9
Common perceptions around Rx to OTC switches challenged Media release 13 February 2013 Pages: 10 - 10
Cost of diabetes mellitus in the US exceeds $US217 billion Media release 13 February 2013 Pages: 10 - 10
Late stent thromboses cost DES cost effectiveness in the US Clinical study 13 February 2013 Pages: 11 - 11
Pneumococcal, meningococcal highest value vax sectors in future Media release 13 February 2013 Pages: 11 - 11
OROS hydromorphone vs ER oxycodone: a close call in OA Clinical study 13 February 2013 Pages: 13 - 13
Majority of chronically ill in US not receiving care due to costs Media release 13 February 2013 Pages: 13 - 13
Ugandans missing out on effective new antimalarials due to cost News item 13 February 2013 Pages: 14 - 14
The antidepressant market in China is predicted to triple by 2012, Media release 13 February 2013 Pages: 14 - 14
Cervarix, GlaxoSmithKline's cervical cancer vaccine, has been confirmed as the vaccine the Dutch National Immunisation Programme (NIP) will supply. Media release 13 February 2013 Pages: 14 - 14
The uptake of next-generation antifungals has intensified the competition in the market for drugs treating severe fungal infections, Media release 13 February 2013 Pages: 15 - 15